The correct selection of patients who will benefit from treatment with IL-6 blockade [9, 34–36] and its timing decreases the probability of its low utility [9, 37–39]; however, inadequate immunosuppression can also impair virus clearance [40], increase the selection of variants of concern [41], and increase the risk of infections [42]. The gene discussed is IL6; the disease is infection.